Back
BioLineRx Ltd. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
22
BLRX
BioLineRx Ltd.
Last Price:
$3.26
Seasonality Move:
-3.99%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBioLineRx Ltd. Stock Forecast
-
Is BioLineRx Ltd. Stock Undervalued?The current BioLineRx Ltd. [BLRX] share price is $3.26. The Score for BLRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
BLRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will BioLineRx Ltd. Stock Go Up Next Year?
Data Unavailable
BioLineRx Ltd. Stock Rating
Data Unavailable
BioLineRx Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biolinerx.com
52-Week Data
52-Week High:
14.70
52-Week Low:
2.30
Prediction Charts
Market Cap:
14.2M
Price in USD:
3.26
Volume:
14.4K
Beta:
1.72
Technical Analysis
SMA50:
3.62
SMA100:
3.77
SMA200:
3.72
52-Wk Change:
-69.85%
Stock Predictions
-
Is BioLineRx Ltd. stock public?Yes, BioLineRx Ltd. is a publicly traded company.
-
What is the BioLineRx Ltd. stock quote today?The BioLineRx Ltd. stock price is 3.26 USD today.
-
How to buy BioLineRx Ltd. stock online?You can buy BioLineRx Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 3.40 | 3.23 | 3.45 | 3.23 |
| Nov-17 | 3.29 | 3.39 | 3.44 | 3.25 |
| Nov-18 | 3.36 | 3.21 | 3.36 | 3.14 |
| Nov-19 | 3.44 | 3.33 | 3.44 | 3.14 |
| Nov-20 | 3.34 | 3.38 | 3.53 | 3.22 |
| Nov-21 | 3.20 | 3.25 | 3.47 | 3.20 |
| Nov-24 | 3.43 | 3.50 | 3.50 | 3.30 |
| Nov-25 | 3.50 | 3.55 | 3.86 | 3.38 |
| Nov-26 | 3.54 | 3.45 | 3.58 | 3.36 |
| Nov-28 | 3.40 | 3.47 | 3.56 | 3.40 |
| Dec-1 | 3.40 | 3.34 | 3.50 | 3.12 |
| Dec-2 | 3.38 | 3.20 | 3.40 | 3.12 |
| Dec-3 | 3.38 | 3.22 | 3.39 | 3.16 |
| Dec-4 | 3.30 | 3.26 | 3.39 | 3.20 |
BioLineRx Ltd. Earnings
Data Unavailable
BioLineRx Ltd. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.52 per share, and a decrease next year of $0.23 per share.
* BioLineRx Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.